esophagus adenocarcinoma
Showing 1 - 8 of 8
Barrett Esophagus, Barretts Esophagus With Dysplasia, Esophagus Adenocarcinoma Trial in United States (EsoGuard)
Recruiting
- Barrett Esophagus
- +2 more
- EsoGuard
-
Heber Springs, Arkansas
- +7 more
Sep 6, 2023
Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)
Not yet recruiting
- Esophagus Adenocarcinoma
- Durvalumab
- +3 more
-
Frankfurt, GermanyInstitute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023
Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)
Not yet recruiting
- Esophagus Cancer
- +9 more
- ActivSight
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center - Dept of Cardiothoracic
Jan 31, 2023
Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Trifluridine/Tipiracil
- +2 more
-
Amiens, France
- +20 more
Jul 26, 2022
Survey Study on Barrett's Esophagus Screening
Recruiting
- Gastroesophageal Reflux Disease
- +2 more
- Primary Care Provider Survey
- +2 more
-
Aurora, Colorado
- +6 more
Jan 20, 2022
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas
Recruiting
- Esophagus Adenocarcinoma
- +2 more
-
Dallas, TexasDallas VA Medical Center
Nov 2, 2021
WATS3D for the Detection of Esophageal Dysplasia
Completed
- Barrett Esophagus
- +2 more
- Diagnostic Test
-
Philadelphia, PennsylvaniaMike Smith
Oct 27, 2021
Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma, Esophagus Adenocarcinoma Trial in Fuzhou (XBI-302 + Nivolumab)
Withdrawn
- Gastric Adenocarcinoma
- +2 more
- XBI-302 + Nivolumab
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Oct 19, 2021